| Status: | Phase 3 |
| Entry Type: | Antibody |
| UNII: | W05CP6IT8R |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanoma | 3 | D008545 | ClinicalTrials |
| Hodgkin Disease | 2 | D006689 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL5314998 |
| FDA SRS | W05CP6IT8R |
CONTENTS